Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2018 Sep;132(3):725-735.
doi: 10.1097/AOG.0000000000002812.

Risk of Cervical Intraepithelial Neoplasia 2 or Worse by Cytology, Human Papillomavirus 16/18, and Colposcopy Impression: A Systematic Review and Meta-analysis

Affiliations
Meta-Analysis

Risk of Cervical Intraepithelial Neoplasia 2 or Worse by Cytology, Human Papillomavirus 16/18, and Colposcopy Impression: A Systematic Review and Meta-analysis

Michelle I Silver et al. Obstet Gynecol. 2018 Sep.

Abstract

Objective: To calculate pooled risk estimates for combinations of cytology result, human papillomavirus (HPV) 16/18 genotype and colposcopy impression to provide a basis for risk-stratified colposcopy and biopsy practice.

Data source: A PubMed search was conducted on June 1, 2016, and a ClinicalTrials.gov search was conducted on June 9, 2018, using key words such as "uterine cervical neoplasms," "cervical cancer," "mass screening," "early detection of cancer," and "colposcopy."

Methods of study selection: Eligible studies must have included colposcopic impression and either cytology results or HPV 16/18 partial genotype results as well as a histologic biopsy diagnosis from adult women. Manuscripts were reviewed for the following: cytology, HPV status, and colposcopy impression as well as age, number of women, and number of cervical intraepithelial neoplasia (CIN) 2, CIN 3, and cancer cases. Strata were defined by the various combinations of cytology, genotype, and colposcopic impression.

Tabulation, integration, and results: Of 340 abstracts identified, nine were eligible for inclusion. Data were also obtained from three unpublished studies, two of which have since been published. We calculated the risk of CIN 2 or worse and CIN 3 or worse based on cytology, colposcopy, and HPV 16/18 test results. We found similar risk patterns across studies in the lowest risk groups such that risk estimates were similar despite different referral populations and study designs. Women with a normal colposcopy impression (no acetowhitening), less than high-grade squamous intraepithelial lesion cytology, and HPV 16/18-negative were at low risk of prevalent precancer. Women with at least two of the following: high-grade squamous intraepithelial lesion cytology, HPV16- or HPV18-positive, and high-grade colposcopic impression were at highest risk of prevalent precancer.

Conclusion: Our results support a risk-based approach to colposcopy and biopsy with modifications of practice at the lowest and highest risk levels.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Population distribution of risk strata combinations. Colposcopy and cytology (A), colposcopy and HPV16/18 (B), and colposcopy, cytology, and HPV16/18. HPV, human papillomavirus; HSIL, high-grade squamous intraepithelial lesions; BD, Becton Dickinson; ALTS, ASCUS/LSIL Triage Study.
Figure 2
Figure 2
Pooled risk estimates by test result. Rank ordered pooled risk estimate of CIN2+ by strata of test results. HPV, human papillomavirus. HSIL, high-grade squamous intraepithelial lesions; CIN, cervical intraepithelial neoplasia.
Figure 3
Figure 3
Risk estimates for CIN2+ based on colposcopy impression and cytology result. I2 only calculated when number of studies is greater than 3. ES, estimated risk of CIN2+; CIN, cervical intraepithelial neoplasia; HSIL, high-grade squamous intraepithelial lesions; BD, Becton Dickinson; ALTS, ASCUS/LSIL Triage Study.
Figure 4
Figure 4
Risk estimates for CIN2+ based on colposcopy impression and HPV16/18 status. I2 only calculated when number of studies is greater than 3. ES, estimated risk of CIN2+; CIN, cervical intraepithelial neoplasia; HPV, human papillomavirus; ALTS, ASCUS/LSIL Triage Study; BD, Becton Dickinson.
Figure 5
Figure 5
Risk estimates for CIN2+ based on colposcopy impression, cytology result, and HPV16/18 status. I2 only calculated when number of studies is greater than 3. B is a continuation of A. ES, estimated risk of CIN2+; CIN, cervical intraepithelial neoplasia; HSIL, high-grade squamous intraepithelial lesions; HPV, human papillomavirus; BD, Becton Dickinson; ALTS, ASCUS/LSIL Triage Study.
Figure 5
Figure 5
Risk estimates for CIN2+ based on colposcopy impression, cytology result, and HPV16/18 status. I2 only calculated when number of studies is greater than 3. B is a continuation of A. ES, estimated risk of CIN2+; CIN, cervical intraepithelial neoplasia; HSIL, high-grade squamous intraepithelial lesions; HPV, human papillomavirus; BD, Becton Dickinson; ALTS, ASCUS/LSIL Triage Study.

References

    1. Howlader NNA, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER Cancer Statistics Review, 1975–2014 National Cancer Institute. Bethesda, MD: posted to the SEER website April 2017 [updated Based on November 2016 SEER data submission. Available from: https://seer.cancer.gov/csr/1975_2014/
    1. Massad LS, Jeronimo J, Schiffman M, et al. Interobserver agreement in the assessment of components of colposcopic grading. Obstet Gynecol. 2008;111(6):1279–84. - PubMed
    1. Khan MJ, Werner C, Darragh TM, et al. ASCCP Colposcopy Standards: Role of colposcopy, benefits, potential harms, and terminology for colposcopic practice. J Low Genit Tract Dis. 2017 - PubMed
    1. Mayeaux EJ, Novetsky AP, Chelmow D, et al. ASCCP Colposcopy Standards: Colposcopy Quality Improvement Recommendations for the United States. J Low Genit Tract Dis. 2017 - PMC - PubMed
    1. Waxman AG, Conageski C, Silver MI, et al. ASCCP Colposcopy Standards: How Do We Perform Colposcopy? Implications for Establishing Standards Journal of Lower Genital Tract Disease. 2017;21(4):235–41. doi: 10.1097/lgt.0000000000000336. - DOI - PMC - PubMed

Publication types

MeSH terms